ESSILORLUXOTTICA 1/2/O.N. (ESLC) - Total Assets
Based on the latest financial reports, ESSILORLUXOTTICA 1/2/O.N. (ESLC) holds total assets worth €63.90 Billion EUR (≈ $74.70 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See ESSILORLUXOTTICA 1/2/O.N. (ESLC) shareholders funds for net asset value and shareholders' equity analysis.
ESSILORLUXOTTICA 1/2/O.N. - Total Assets Trend (2021–2025)
This chart illustrates how ESSILORLUXOTTICA 1/2/O.N.'s total assets have evolved over time, based on quarterly financial data.
ESSILORLUXOTTICA 1/2/O.N. - Asset Composition Analysis
Current Asset Composition (December 2025)
ESSILORLUXOTTICA 1/2/O.N.'s total assets of €63.90 Billion consist of 18.8% current assets and 81.2% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 5.6% |
| Accounts Receivable | €3.64 Billion | 5.7% |
| Inventory | €3.54 Billion | 5.5% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €9.75 Billion | 15.3% |
| Goodwill | €31.01 Billion | 48.5% |
Asset Composition Trend (2021–2025)
This chart illustrates how ESSILORLUXOTTICA 1/2/O.N.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ESLC company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: ESSILORLUXOTTICA 1/2/O.N.'s current assets represent 18.8% of total assets in 2025, an increase from 15.6% in 2021.
- Cash Position: Cash and equivalents constituted 5.6% of total assets in 2025, up from 5.5% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 63.0% of total assets, a decrease from 69.0% in 2021.
- Asset Diversification: The largest asset category is goodwill at 48.5% of total assets.
ESSILORLUXOTTICA 1/2/O.N. Competitors by Total Assets
Key competitors of ESSILORLUXOTTICA 1/2/O.N. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Alcon AG
SW:ALC
|
Switzerland | CHF31.53 Billion |
|
iRay Technology Co Ltd
SHG:688301
|
China | CN¥11.33 Billion |
|
Shenyang Xingqi Pharmaceutical Co Ltd
SHE:300573
|
China | CN¥2.42 Billion |
|
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN
|
USA | $32.49 Million |
|
Jiangsu Nanfang Medical
SHG:603880
|
China | CN¥993.46 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$141.20 Million |
|
MEDIMI AB AK
F:79T
|
Germany | €1.70 Million |
|
I.Ceram SA
PA:ALICR
|
France | €3.91 Million |
ESSILORLUXOTTICA 1/2/O.N. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.10 | 1.11 | 0.88 |
| Quick Ratio | 0.78 | 0.76 | 0.62 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €1.11 Billion | €966.00 Million | €-1.31 Billion |
ESSILORLUXOTTICA 1/2/O.N. - Advanced Valuation Insights
This section examines the relationship between ESSILORLUXOTTICA 1/2/O.N.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.41 |
| Latest Market Cap to Assets Ratio | 1.46 |
| Asset Growth Rate (YoY) | -0.6% |
| Total Assets | €63.90 Billion |
| Market Capitalization | $93.24 Billion USD |
Valuation Analysis
Above Book Valuation: The market values ESSILORLUXOTTICA 1/2/O.N.'s assets above their book value (1.46x), reflecting positive investor sentiment about the company's future prospects.
Slight Asset Contraction: ESSILORLUXOTTICA 1/2/O.N.'s assets decreased by 0.6% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for ESSILORLUXOTTICA 1/2/O.N. (2021–2025)
The table below shows the annual total assets of ESSILORLUXOTTICA 1/2/O.N. from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €63.90 Billion ≈ $74.70 Billion |
-0.57% |
| 2024-12-31 | €64.26 Billion ≈ $75.13 Billion |
+6.18% |
| 2023-12-31 | €60.52 Billion ≈ $70.76 Billion |
-0.06% |
| 2022-12-31 | €60.56 Billion ≈ $70.80 Billion |
+1.93% |
| 2021-12-31 | €59.41 Billion ≈ $69.46 Billion |
-- |
About ESSILORLUXOTTICA 1/2/O.N.
EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, sunglasses, and instruments and equipment in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific. It offers lens, eyewear, contact lenses, reading glasses under Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Ni… Read more